Arch Therapeutics
Stock Forecast, Prediction & Price Target
Arch Therapeutics Financial Estimates
Arch Therapeutics Revenue Estimates
Arch Therapeutics EBITDA Estimates
Arch Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 9/30/2021 | 9/30/2022 | 9/30/2023 | 9/30/2025 | 9/30/2026 | 9/30/2027 | 9/30/2028 |
Revenue
% change YoY
| $11.56K N/A | $15.65K 35.33% | $75.72K 383.79% | Avg: $221.95M Low: $221.95M High: $221.95M avg. 293003.90% | Avg: $328.87M Low: $328.87M High: $328.87M avg. 48.17% | Avg: $44.32M Low: $44.32M High: $44.32M avg. -86.52% | Avg: $55.98M Low: $55.98M High: $55.98M avg. 26.31% |
Net Income
% change YoY
| $-6.56M N/A | $-4.27M 34.91% | $-6.98M -63.30% | Avg: $31.94M Low: $31.94M High: $31.94M avg. 557.40% | Avg: $46.51M Low: $46.51M High: $46.51M avg. 45.62% | Avg: $4.79M Low: $4.79M High: $4.79M avg. -89.68% | Avg: $5.96M Low: $5.96M High: $5.96M avg. 24.35% |
EBITDA
% change YoY
| $-6.19M N/A | $-5.70M 7.91% | $-3.88M 31.92% | Avg: $-44.38M Low: $-44.38M High: $-44.38M avg. -1042.79% | Avg: $-65.77M Low: $-65.77M High: $-65.77M avg. -48.17% | Avg: $-8.86M Low: $-8.86M High: $-8.86M avg. 86.52% | Avg: $-11.19M Low: $-11.19M High: $-11.19M avg. -26.31% |
EPS
% change YoY
| -$5.97 N/A | -$3.56 40.36% | -$2.27 36.23% | Avg: $10.39 Low: $10.39 High: $10.39 avg. 557.70% | Avg: $15.13 Low: $15.13 High: $15.13 avg. 45.62% | Avg: $1.56 Low: $1.56 High: $1.56 avg. -89.68% | Avg: $1.94 Low: $1.94 High: $1.94 avg. 24.35% |
Operating Expenses
% change YoY
| $6.36M N/A | $5.67M -10.83% | $5.04M -11.12% | Avg: $34.69B Low: $34.69B High: $34.69B avg. 688042.68% | Avg: $51.41B Low: $51.41B High: $51.41B avg. 48.17% | Avg: $6.92B Low: $6.92B High: $6.92B avg. -86.52% | Avg: $8.75B Low: $8.75B High: $8.75B avg. 26.31% |
FAQ
What is Arch Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 134.42% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is 31.94M, average is 31.94M and high is 31.94M.
What is Arch Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 73247.96% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $221.95M, average is $221.95M and high is $221.95M.
What is Arch Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 134.49% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is $10.39, average is $10.39 and high is $10.39.